Linda C. Wase

Inga fler pågående positioner

Health Technology

Consumer Services

Profil

Linda C.
Wase worked as an Executive Vice President-Medical Affairs at KP Pharmaceuticals LLC from 2007 to 2011.
She then worked as a Vice President-Medical Services at GSK Plc from 2012 to 2015.
Later, she worked as a VP-Clinical Operations & Medical Affairs at Trevena, Inc. Dr. Wase completed her undergraduate degree from Union College (New York) and earned a doctorate degree from New York Medical College.

Tidigare kända positioner av Linda C. Wase

Företag	Position	Slut
GSK PLC	Teknisk/Vetenskaplig/F&U Direktör	2015-01-01
KP Pharmaceuticals LLC KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets and sells generic pharmaceutical products	Teknisk/Vetenskaplig/F&U Direktör	2011-01-01
TREVENA, INC.	Teknisk/Vetenskaplig/F&U Direktör	-

Se detaljerna i Linda C. Wases erfarenhet

Linda C. Wases utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Linda C. Wases erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	5
KP Pharmaceuticals LLC KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets and sells generic pharmaceutical products	Health Technology
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
Union College (New York) Union College (New York) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
New York Medical College New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Trevena, Inc. Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system	Health Technology